Additional file 6 of DNA methylation predicts the outcome of COVID-19 patients with acute respiratory distress syndrome

Additional file 6: Table S6. Analysis of dead and recovered+A3 COVID-19 patients for immune cell proportions. A. Summary of different models tested for immune cell proportions. Adjusted R2, residual standard error (sigma), AIC, and p-value for each tested model for each cell type are shown. The following models were tested, mod1; Age + MV days + Gender + ICU LoS + ECMO + Nosocomial infections, mod2; Age + Gender + ICU LoS + ECMO + Nosocomial infections, mod3; Age + MV days + ICU LoS + ECMO + Nosocomial infections, mod4; Age + ECMO + Nosocomial infections, mod5; Age + Nosocomial infections, mod6; Age, mod7; no covariates. B. Immune cell differences between dead and recovered at baseline, C. Immune cell differences between dead and recovered at last time point.

补充材料6：表S6。死亡与康复A3亚型新冠患者免疫细胞比例分析。
A. 免疫细胞比例分析所用测试模型汇总。针对每种细胞类型，展示了各测试模型的校正R²（Adjusted R2）、残差标准误（sigma）、赤池信息准则（AIC）及P值。本次测试的模型如下：模型1（mod1）：年龄+机械通气天数+性别+ICU住院时长+体外膜肺氧合（ECMO）+医院获得性感染；模型2（mod2）：年龄+性别+ICU住院时长+ECMO+医院获得性感染；模型3（mod3）：年龄+机械通气天数+ICU住院时长+ECMO+医院获得性感染；模型4（mod4）：年龄+ECMO+医院获得性感染；模型5（mod5）：年龄+医院获得性感染；模型6（mod6）：仅纳入年龄；模型7（mod7）：无协变量。
B. 基线时死亡与康复患者的免疫细胞差异
C. 末次随访时间点死亡与康复患者的免疫细胞差异